Respirology

A new tool, the CHILDhood Asthma Risk Tool, or CHART, helps providers determine the risk of childhood asthma. A study on its efficacy was published in JAMA, concluding it could be used as a routine screening tool in primary care. 

Ryaltris was approved for symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms in people over six years old.